Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania (NCT06635733) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania
Tanzania100 participantsStarted 2025-01-06
Plain-language summary
The goal of this clinical trial is to evaluate whether the integration of in-person skills practice (ISP) with an adaptive e-learning platform can improve refresher learning progress (RLP) among healthcare providers in pediatric care settings in Tanzania.
The main questions it aims to answer are:
Can healthcare providers who participate in ISP sessions facilitated by clinical champions achieve greater improvements in refresher learning progress (RLP)? Will providers in the intervention group demonstrate improved metacognition and practical skill performance compared to those in the control group? Researchers will compare healthcare providers using the ISP digital platform (Rhapsode Capable™) to providers using paper-based ISP to see if the digital platform results in significantly higher RLP and fewer skill-based errors.
Participants will:
Complete adaptive e-learning modules focused on pediatric care topics (e.g., newborn resuscitation, severe malnutrition).
Participate in ISP sessions where clinical champions provide feedback and assess performance.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthcare providers actively involved in pediatric care at one of the selected healthcare centers.
* Completion of core Pediatric Acute Care Education (PACE) adaptive learning modules prior to study participation.
* Willingness to participate in In-Person Skills Practice (ISP) sessions.
* Ability to engage with either the Rhapsode Capable™ platform (intervention group) or paper-based ISP methods (control group).
* Minimum proficiency in written and spoken English.
Exclusion Criteria:
* Healthcare providers not involved in pediatric or newborn clinical care at the time of recruitment.
* Providers unable or unwilling to attend ISP sessions facilitated by clinical champions.
* Individuals with no prior engagement in the PACE program.
* Providers with significant technological barriers that prevent the use of the Rhapsode Capable™ platform (for the intervention group only).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Median Refresher Learning Progress (RLP) Among Providers
Timeframe: 16 (Pilot) or 32 (repilot) weeks from baseline to study completion. Each participant's progress will be tracked weekly throughout the 16/32-week intervention period.